Covaris' European subsidiary to commence operations on May 1, 2014

NewsGuard 100/100 Score

Covaris, Inc., an innovator in the life science tools and the clinical diagnostic market spaces, announced today that its European subsidiary, Covaris Ltd, which is located in the United Kingdom, will commence operations on May 1, 2014.

Covaris Ltd has sales, service, and application representatives throughout Europe providing a high level of support for recently launched application kits such as truXTRAC™ for FFPE DNA extraction  and truChIP™ for Chromatin shearing. Covaris, known for its proprietary Adaptive Focused Acoustics™ (AFA) technology, will enhance delivery times by shipping consumables, including the new microTUBE LV™, which enables DNA fragmenting in volumes as low as 15µl, from its European distribution centre in Brighton, England.

Covaris Founder and CEO, Jim Laugharn adds: "As analytical technologies for the life sciences become more sophisticated, the need for precise, accurate, and high-quality sample preparation becomes a critical prerequisite.  By establishing a local presence with Covaris Ltd, we will be better positioned to serve our European customers by providing direct product, application, and customer support services."

Covaris, Ltd. will be managed locally by Dr. Adrian Palmer who joined Covaris in 2013 and brings 15 years' experience in scientific, customer support and commercial roles acquired at Roche, Sirigen (a BD company) and Lab 21.

 SOURCE Covaris, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Link between aldehydes and premature aging revealed